EXTON, Pa., Oct. 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will be presenting at several upcoming healthcare investment conferences.
Vincent Milano, president and chief executive officer of ViroPharma, will present at the Oppenheimer 20th Annual Healthcare Conference at 4:30 P.M. EST on Tuesday, November 3, 2009. The conference is being held at the Waldorf=Astoria in New York City.
Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Credit Suisse 2009 Healthcare Conference at 12:00 P.M. MST on Wednesday, November 11, 2009. The conference is being held at the Arizona Biltmore Hotel in Phoenix, AZ.
William Roberts, vice president, corporate communications will present at the Lazard Capital Markets 6th Annual Healthcare Conference at 2:45 P.M. EST on Wednesday, November 18, 2009. The conference is being held at the St. Regis Hotel in New York City.
ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary
|SOURCE ViroPharma Incorporated|
Copyright©2009 PR Newswire.
All rights reserved